Clinical Trial Update: Role of Ascorbic Acid Infusion in Critically Ill Patients With Transfusion Related Acute Lung Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intravenous ascorbic acid for critically ill patients with transfusion-related acute lung injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Transfusion-related Acute Lung Injury

Drugs mentioned

• Ascorbic acid (Vitamin C)

Snippet

Sponsor: Damanhour University | Conditions: Acute Lung Injury, Transfusion Related | Phase 2 | Status: COMPLETED